VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,440 | -3.5% | 4,057 | +42.6% | 0.00% | – |
| Q2 2023 | $32,585 | +19.1% | 2,846 | -19.8% | 0.00% | – |
| Q1 2023 | $27,370 | +44.1% | 3,550 | +14.5% | 0.00% | – |
| Q4 2022 | $19,000 | +26.7% | 3,100 | +24.0% | 0.00% | – |
| Q3 2022 | $15,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -31.8% | 2,500 | -16.7% | 0.00% | – |
| Q1 2022 | $22,000 | +450.0% | 3,000 | +100.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 1,500 | +1160.5% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 119 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |